AbbVie
Highly Engaged Employees
Manufacturing · Illinois, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
1 N Waukegan Rd, North Chicago, Illinois...Phone Number
(847) 932-7900Website
www.abbvie.comRevenue
$64.4 BillionStock Symbol
ABBVIndustry
About AbbVie
AbbVie Org Chart
Is AbbVie your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once AbbVie has new funding data
Check out if AbbVie is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at AbbVie
Earning: See what the market has to say on AbbVie recently announced quarterly report
Product Launch: Get notified when AbbVie launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if AbbVie had a recent Job posting/layoffs
AbbVie, which may be a good buyer, showed buying intent in Masked Content Topic
Check if AbbVie has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at AbbVie
Find 2 more new buyers
Company Profile Activity
Activity Insights
AbbVie is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AbbVie is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AbbVie.
AbbVie Tech Stack
A closer look at the technologies used by AbbVie
Most Recent Scoops
AbbVie News & Media
How to Choose a CRO for DMPK Studies: Key Capabilities and Case Examples
SAN DIEGO , CA, UNITED STATES, September 30, 2026 /EINPresswire.com/ -- Key Takeaways: A CRO’s DMPK capabilities should match the program’s development stage and scientific questions. Relevant services include in vitro ADME, in vivo pharmacokinetics, …AbbVie Highlights Positive Results from the Phase 2 APEX Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at EADV 2026
Phase 2 data in adults with atopic dermatitis showed that all three zumilokibart dose regimens met the primary endpoint, with significantly greater improvements in Eczema Area and Severity Index -75 (EASI-75) response rates versus placebo at Week 16 1 The mid-dose regimen was selected for...AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
AbbVie presents 60 abstracts and presentations from a robust portfolio spanning across alopecia areata, atopic dermatitis, hidradenitis suppurativa, non-segmental vitiligo, psoriasis and psoriatic arthritis New data for risankizumab and upadacitinib provide further evidence supporting...U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease
JUVMO™ is the first and only selective D1/D5 receptor agonist approved for adults with Parkinson's disease1 Taken once daily with or without levodopa therapy, JUVMO offers patients a differentiated approach to motor symptom control across the Parkinson's disease continuum Approval is...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding AbbVie
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outc... Read More